Synopsis:- The cement business is being consolidated into a single large platform with 107 MTPA capacity. A major brokerage sees 36% upside with a ₹750 target, supported by scale benefits, rising efficiency, and heavy capex that may turn net debt briefly before...
Synopsis: A licensing deal for Semaglutide across 26 countries, with launches planned post-2026 patent expiry. Q2FY26 revenue grew 14% to ₹1,354 crore, while profit increased 20% to ₹260 crore, supported by strong branded generics exposure and global reach. The shares...
Synopsis:- A major FII bought 70.5 lakh shares in a block deal worth ₹108 crore. Q2FY26 revenue grew 14% to ₹2,354 crore, while profit surged 82% to ₹133 crore, supported by strong segment growth and large-scale manufacturing capacity. The shares of the automotive...
Synopsis:- The company won solar project orders worth 51.3 MW, boosting long-term visibility with a 25-year PPA at ₹2.74/unit. Despite 211% revenue growth to ₹9.37 crore, margins compressed sharply, with operating profit falling and profitability remaining under...
SYNOPSIS: Several stocks have triggered a golden crossover on December 22, 2025, signalling potential bullish momentum. However, recent price action remains mixed, with mild intraday declines despite healthy volumes, indicating short-term caution even as technical...
Synopsis:- The shares of the company slid 7% after announcing a board meeting to consider fresh fundraising, sparking dilution worries. Despite strong Q2 growth with 32% revenue and 82% profit rise, investors remain cautious given limited cash, a $2 billion revenue...
Synopsis:- A pharma CDMO stock jumped 8% after a mutual fund bought 72.78 lakh shares worth ₹311.5 crore in a bulk deal. In Q2, pressure showed with revenue down 2%, profit falling 36%, and operating margins easing from 12% to 9%. The shares of contract development...
Synopsis:- A micro-cap engineered products stock hit a 5% upper circuit after signing a strategic Middle East MoU for an upcoming defence order. Shares traded near ₹794 with a ₹468 crore market cap, while revenue rose 2% year-on-year amid margin pressure and ongoing...
Synopsis:- The company is preparing for a 2028 IPO by cutting debt from ₹53,546 crore to ₹20,464 crore, adding 2,000 stores annually, and strengthening its quick-commerce network. With 19,821 outlets and 18% revenue growth, its strategy focuses on profitability,...
Synopsis:- The NBFC is gaining traction after multiple Buy calls, with a target of ₹1,225, implying 36% upside. Strong institutional backing, a $4.4 billion capital infusion, 15.7% AUM growth, and steady Q2 performance continue to improve long-term growth visibility....
